Stomach bug treatment may boost blood platelets in ITP patients
NCT ID NCT07150286
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether treating Helicobacter pylori (a common stomach infection) with antibiotics can raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding and bruising. Researchers enrolled 100 adults with ITP in Baghdad, tested them for H. pylori, and gave those who were positive a 14-day course of antibiotics. Platelet counts were measured before and four weeks after treatment to see if eradicating the infection helped.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Levofloxacin-based triple therapy (antibiotics and acid reducer)
What this could lead to
If successful, this could offer a simple antibiotic treatment to improve platelet counts in some ITP patients, reducing bleeding risk.
What could go wrong
This is a small, completed study in one city, so results may not apply broadly. Not all ITP patients have H. pylori, and antibiotics can cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Al-Mustansiriyah University - college of pharmacy - clinical pharmacy department
Baghdad, Baghdad Governorate, 10001, Iraq